Cargando…
CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers
BACKGROUND: The Cancer Testis Antigens (CTAs) are a group of genes that are highly expressed in the normal testis and several types of cancer. Due to their restricted expression in normal adult tissues, CTAs have been attractive targets for immunotherapy and biomarker development. In this work, we d...
Autores principales: | Kim, John J, Rajagopalan, Krithika, Hussain, Basil, Williams, Brenten H, Kulkarni, Prakash, Mooney, Steven M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177615/ https://www.ncbi.nlm.nih.gov/pubmed/24252580 http://dx.doi.org/10.1186/2050-7771-1-22 |
Ejemplares similares
-
Cancer/testis antigens and obligate participation in multiple hallmarks of cancer: an update
por: Mooney, Steven M, et al.
Publicado: (2016) -
Cancer/Testis Antigen PAGE4, a Regulator of c-Jun
Transactivation, Is Phosphorylated by Homeodomain-Interacting Protein
Kinase 1, a Component of the Stress-Response Pathway
por: Mooney, Steven M., et al.
Publicado: (2014) -
Cancer/Testis Antigens: “Smart” Biomarkers for Diagnosis and Prognosis of Prostate and Other Cancers
por: Kulkarni, Prakash, et al.
Publicado: (2017) -
Centrin-2 (Cetn2) mediated regulation of FGF/FGFR gene expression in Xenopus
por: Shi, Jianli, et al.
Publicado: (2015) -
Prostate-associated gene 4 (PAGE4), an intrinsically disordered cancer/testis antigen, is a novel therapeutic target for prostate cancer
por: Kulkarni, Prakash, et al.
Publicado: (2016)